Xolair (the trade name for Omalizumab), is a drug that has been approved to treat teenagers and adults with severe allergic asthma since its introduction in Australia in 2002. Approved by the U.S. Food and Drug Administration (FDA) in 2014, it has been held out as being particularly effective for people who cannot be treated with H1 antihistamines or do not benefit from high doses of corticosteroids. It has also been used to treat people who suffer chronically from hives.
A number of adverse side effects have been linked to the use of Xolair, including:
- Anaphylactic shock or anaphylaxis (a life-threatening allergic reaction)
- Increased risk of heart disease
- Increased risk of stroke
- Masking of warning signs of certain cancers
If you or someone you love has suffered injury after being prescribed Xolair, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
I often am asked by clients how they can avoid probate. In some situations, it is appropriate to tak…Read More 12 Jul 2019, Friday
What is the Hatch Act and How Did Kellyanne Conway Violate It?
Office of Special Counsel Calls White House Counselor a “Repeat Offender” and Calls for…Read More 25 Jun 2019, Tuesday
TEVA Pharmaceutical Settles Opioid Lawsuit Before Trial
Israeli Drug Company Agrees to Pay $85 Million A second major pharmaceutical company has decided to…Read More 28 May 2019, Tuesday